---
schema_version: "secwatch.filing_event.v1"
accession: "0000064803-25-000006"
form_type: "8-K"
ticker: "CVS"
cik: "0000064803"
company_name: "CVS HEALTH Corp"
filed_at: "2025-02-12T23:59:59+00:00"
generated_at: "2026-05-26T23:06:08.951713+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# CVS Health Q4 revenue up 4.2% to $97.7B, adjusted EPS falls 44% to $1.19; FY25 guidance below consensus

## Summary
- GAAP diluted EPS $1.30 (down $0.28 YoY); adjusted EPS $1.19 (down $0.93 YoY) on Health Care Benefits weakness.
- Full-year 2024 total revenues $372.8B (+4.2% YoY); GAAP diluted EPS $3.66, adjusted EPS $5.42.
- Health Care Benefits segment hurt by continued utilization pressure and unfavorable Medicare Advantage star ratings.
- 2025 guidance: GAAP diluted EPS $4.58-$4.83; adjusted EPS $5.75-$6.00; cash flow from ops ~$6.5B.
- Pharmacy & Consumer Wellness segment showed growth, but overall earnings pressured by insurance challenges.

## SEC filing metadata
- accession: 0000064803-25-000006
- form_type: 8-K
- ticker: CVS
- cik: 0000064803
- company_name: CVS HEALTH Corp
- filed_at: 2025-02-12T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/64803/000006480325000006/0000064803-25-000006-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/64803/000006480325000006/cvs-20250212.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000064803-25-000006
- JSON: https://secwatch.observer/filing/0000064803-25-000006.json
- Plain text: https://secwatch.observer/filing/0000064803-25-000006.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.